Sichuan Kelun-Biotech Biopharmaceutical Co Ltd - Class H Shares

HKSE:06990 (China)   Class H Shares
HK$ 172.30 (-0.75%) Dec 24
At Loss
P/B:
11.11
Market Cap:
HK$ 39.16B ($ 5.04B)
Enterprise V:
HK$ 36.11B ($ 4.64B)
Volume:
276.56K
Avg Vol (2M):
353.84K
Trade In:
Volume:
276.56K
At Loss
Avg Vol (2M):
353.84K

Business Description

Description
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is an innovative biopharmaceutical company committed to the R&D, manufacturing and commercialization of novel drugs to address medical needs in China and globally. It is one of the first movers in the development of antibody-drug conjugates (ADCs), with over a decade of accumulated experience in ADC development. The company takes a systematic, indication-oriented approach to target the world's prevalent or hard-to-treat cancers, and other diseases and conditions affecting a large and underserved population.
Name Current Vs Industry Vs History
Cash-To-Debt 75.77
Equity-to-Asset 0.84
Debt-to-Equity 0.01
Debt-to-EBITDA -0.42
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.24
Distress
Grey
Safe
Beneish M-Score -3.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate 14.04

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 28.85
9-Day RSI 37.19
14-Day RSI 42.41
6-1 Month Momentum % -1.75
12-1 Month Momentum % 61.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.7
Quick Ratio 5.59
Cash Ratio 5.23
Days Inventory 36.51
Days Sales Outstanding 2.17
Days Payable 178.6

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -0.9

Financials

HKSE:06990's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 2,029.254
EPS (TTM) (HK$) -0.961
Beta 0
Volatility % 60.03
14-Day RSI 42.41
14-Day ATR (HK$) 9.124286
20-Day SMA (HK$) 183.505
12-1 Month Momentum % 61.54
52-Week Range (HK$) 63.65 - 223.8
Shares Outstanding (Mil) 227.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Frequently Asked Questions

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)'s stock price today?
The current price of HKSE:06990 is HK$172.30. The 52 week high of HKSE:06990 is HK$223.80 and 52 week low is HK$63.65.
When is next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990)?
The next earnings date of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) is .
Does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) pay dividends? If so, how much?
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd(HKSE:06990) does not pay dividend.

Press Release

Subject Date
No Press Release